The mission of Healthy Clinic is to become a primary provider of European

integrative medicine in the United States. Through the Osteolitic Treatment

Centers and the “Five Steps to Health” it will offer a combination

of both alternative and western treatment modalities,

providing patients with a unique and innovative

approach to medicine. The company slogan is:

“INNOVATION THRU INTEGRATION”

Healthy Clinic

Confidential Business Plan - Sample

The following dashboard highlights the results of the financial analysis, expected company performance, and

summary of market break down. The reader may use this page as a quick reference visual aid to quickly understand

the expected financial performance of the company.

2

1. Executive Summary

Healthy Clinic, LLC is affiliated with Healthy Clinic (also referred to as “HC”), a German-based entity that

utilizes a global network of doctors, practitioners, clinics, universities and hospitals to promote better health

and patient care through the integration of alternative and cutting edge modern medicine. The Osteolitic

treatment concept implements this integrative approach, offering patients treatment modalities that may not be

available in conventional medicine and integrates them into their current therapy. At the same time Osteolitic

patients also get access to a global network of treatment centers and medical professionals including a flagship

treatment facility in Frankfurt, Switzerland.

Healthy Clinic invested in the U.S. since a large proportion of its current client base originated in the United

States and there is increasing demand for local access to the innovative range of treatments the company offers

without having to travel abroad. Healthy Clinic, LLC will therefore do business in the United States and has

received around $2.1 million in funding to date, enabling it to acquire state-of-the-art medical equipment,

appoint a team of highly talented professionals and to engage in an exhaustive marketing campaign to promote

its services. As part of its overall growth strategy, the company has been constructing a 3,000 sq. ft. penthouse

facility in Beverly Hills. To help develop this new center and to fund the subsequent expansion of its U.S.

presence, the company has secured an additional $1.5 million in funding from its co-owners, with prospective

E-2 visa petitioner Mr. John Smith, who currently holds German citizenship contributing the significant sum

of $722,000 from his personal funds. Mr. Beyer, who is the founder and current CEO of German-based affiliate

Healthy Clinic Ltd., will further be installed as CEO of Healthy Clinic, LLC under the aforementioned E-2 visa

petition, using his considerable entrepreneurial, leadership and industry skills to successfully direct and develop

the growing U.S. operations.

Under the experience leadership of Mr. Beyer, the company plans to broaden its reach across the U.S.,

partnering with an increasing number of satellite centers as well as investing considerable resources in actively

promoting its services. Securing high-profile clients, including celebrities, will help generate consumer

awareness, as will the hosting of engaging events and launch shows. These marketing activities will be

underpinned by strong result driven approach to patient services, with clients benefitting from leading edge

holistic care delivered by highly credentialed industry professionals.

The chart to the right illustrates the growth potential of the company by highlighting key financial metrics –

annual sales, net profits, gross margin, and personnel headcount – over the next five years.

3

In 2015 the company will achieve sales of $2.3 million, an increase on existing revenue levels, as a result of its

investment in marketing and on the strength of the services offered. The new flagship center in Beverly Hills

will help drive future revenue growth, with sales forecast to rise from $3.1 million in 2016 to over $9.2 million

by the end of 2019. Growth in net profits will eventually mirror this upward trend following a small profit of

around $5,500 in 2015 as the company absorbs expansion costs. Net profits for 2016, are expected to reach

$273,000. Improvements in the net

margin, as the business reaches optimal

efficiency, coupled with increasing

demand for services, to over $2.7 million

by 2019. The improvement in profits and

continual growth in market exposure and

sales revenues will naturally lead to a

growth in the net worth of the business,

which is expected to reach around $6.7

million by 2019.

1.1 Objectives

Strategic

Firmly establish Healthy Clinic, LLC as a leading provider of holistic, integrative medical treatments in

the U.S. developing a high profile medical practice.

To franchise the Osteolitic concept to 20 doctors’ offices throughout the United States in major

metropolitan areas in the next 2 years

To develop a broad network of satellite centers across the U.S. and North America.

To market and introduce German Aminopeptide and Thymus products to the U.S. doctors.

Operational

Successfully launch 3,000 sq. ft. penthouse treatment center in Beverly Hills.

To expand its current staff to 15 full-time U.S. professionals by the end of 2019.

To install John Smith from Healthy Clinic Switzerland office as CEO to oversee the corporate

administration operations in the United States.

0

5

10

15

20

$0

$2,000

$4,000

$6,000

$8,000

$10,000

2015 2016 2017 2018 2019

Per

sonn

el

Tho

usan

ds

Synergy Health 5-Year Highlights

Sales Gross Margin Net Profit Personnel

4

2 Company Summary

Healthy Clinic Ltd. was established by Mr. John Smith in 2009. The

company is based in Switzerland and operates a medical tourism business

facilitating travel and medical care for patients by matching them

throughout a global network of healthcare professionals and institutions.

The company opened in the United States (California) in November 2010

installing Mr. Mark Knight as the President of Healthy Clinic. In 2011 the

Osteolitic Treatment Center was opened in Frankfurt, Switzerland with Philip Battiade joining Healthy Clinic

Ltd. as its Medical Director. From this point on Healthy Clinic Ltd. offered in-house treatments as well as

referring patients to partner clinics.

In late 2011 the Osteolitic concept was introduced to the U.S. through a temporary partnership with Dr. Leigh

Erin Conneally; this was carried out in a specially designed three-room treatment facility at the Center for New

Medicine in Irvine, CA. During the same period a similar partnership was developed with the Sanoniv Medical

Institute in Rosarito, Mexico. In December 2013 Healthy Clinic, LLC opened a small one-room treatment

center in Greater Los Angeles, before identifying a premium location in Beverly Hills as an ideal position to

develop a permanent treatment facility with work commencing on the new 3,000 sq. ft. facility in 2014 with

completion due in early 2015.

The Osteolitic Treatment Center’s are managed by Healthy Clinic, implementing and promoting integrative

medicine, who’s holistic approach addresses the full range of physical, emotional, mental, social, spiritual and

environmental influences in the diagnostic and treatment of a patient. It is not a new form of alternative

medicine, but the integration of proven scientific medicine with safe supportive methods, while putting

emphasis on patient education regarding treatment options, lifestyle and nutrition. The guiding principle for

the choice of treatment is to be: as non-invasive as possible and as non-toxic as possible. The Osteolitic

Treatment Centers are designed and managed to create a healing atmosphere in a luxury “spa-like” environment

with the goal to set itself apart from conventional doctor´s offices.

With the Five Steps to Health treatment approach developed by Philip Battiade, Osteolitic provides patients

with a roadmap for optimal health and rejuvenation. It consists of immune modulation therapies, vitalizing

infusions of vitamins, minerals, amino acids, and trace elements, bodywork, massage, aromatherapy, osteopathy,

homeopathic supplements and herbal treatments as well as cutting edge modern treatment modalities such as

regional hyperthermia, genetic testing and whole body thermography. This complex rehabilitation program has

5

3 Services

Healthy Clinic offers seven (7) different services in the United States. If the

company is successful in achieving the desired market penetration, then it

plans to introduce further services, including:

Amino peptide Therapy

Biological Cancer Program

Stem Cell Therapy

Autoimmune Program

Bodywork

IV therapies

Lyme Program

The table below summarizes the most popular services offered by the company, highlighting key characteristics

– typical margins, average profit per development etc. – associated with each type.

3.1 Service Description

Amino peptide Therapy includes 30 minutes of consultation with an Osteolitic practitioner HC health coach at

a partner facility before going through the procedure. The therapy consumes 15 vials of nutritional supplements

imported from Switzerland. Follow-up consultation is scheduled normally after three (3) to six (6) weeks of the

therapy. The complete therapy including the initial consultation costs $3,750 when done in-house. If sold to

other practitioners Healthy Clinic charges $1,550. If sold as a product directly to a consumer the cost is $1,275.

The Lyme Program is also offered in two variations, either the Lyme Support Program or the Lyme Treatment

Program. The Lyme Support Program can be performed at any of the Osteolitic Treatment Centers or satellite

offices in the United States. This consists of a series of IV treatments performed within a 4-6 week period. The

ServicesAverage Unit Sales

per Month in Year 1Price Direct Unit Cost Contrib. Margin %

Average Monthly

Margins in Year 1

Aminopeptide (therapy & product) 20 $3,750 $450 88% $66,000

Integrative cancer care program 1 $20,000 $5,500 73% $18,125

Stem cell therapy program 3 $18,500 $9,600 48% $25,217

Autoimmune & lyme programs 5 $6,800 $1,250 82% $27,750

Bodywork & IV therapies 77 $130 $45 65% $6,566

6

cost of the program is approximately $7,500. At this time, the Lyme Program including stem cell therapy can

only be performed at the Osteolitic Treatment Center in Switzerland.

Bodywork, Massage, and IV Therapies are performed at the Healthy Clinic offices in Beverly Hills or San

Anselmo. These may also be part of a follow-up or maintenance treatment for patients planning to travel to

Switzerland for treatment or returning from there. Bodywork and Massage treatment consists of four (4) to six

(6) consecutive sessions, take 30-90 minutes and require the constant presence of a therapist. These elements

drive up the cost of sales. IV Therapies treatment take approximately three (3) hours. Several patients can be

supervised at once by just one nurse or therapist. These therapies usually consist of four (4) to eight (8)

consecutive IV sessions.

The graph below illustrates the key characteristics of the company’s core services.

0%

20%

40%

60%

80%

100%

$0

$5,000

$10,000

$15,000

$20,000

$25,000

Aminopeptide(therapy &product)

Integrativecancer care

program

Stem celltherapyprogram

Autoimmune& lyme

programs

Bodywork &IV therapies

Synergy Health Services

Price Direct Unit Cost Contrib. Margin %

7

4 Marketing Analysis

This section will examine the key market characteristics, both locally and

nationally, that the leadership of Healthy Clinic, LLC consider essential to

the strategic planning and decision-making processes of the company.

4.1 Geographical Summary

Healthy Clinic, LLC is located in the city of Beverly Hills, California.

Beverly Hills is an affluent city with a population of 34,6581, forming part of Los Angeles County, a wider

metropolitan region of over 9.8 million residents. The city, and neighboring West Hollywood, are entirely

surrounded by the city of Los Angeles, bordered by the neighborhoods of Bel Air, Holmby Hills, Santa Monica

Mountains and Brentwood. Beverly Hills has long been associated with actors and celebrities since Hollywood

icons Douglas Fairbanks and Mary Pickford built their mansion here in the 1920s. Nowadays, the city is

synonymous with wealth, success and stardom and forms part of the so-called ‘Platinum Triangle’, an informal

name for a concentration of adjacent wealthy districts, with Bel Air and Holmby Hills. Beverly Hills residents

have an average per capita disposable income of almost $76,000 per year, almost three times the State and

national average, while median household income is over $88,000 annually; again significantly higher than the

national average ($51,000).

4.2 Market Segmentation

The chart to the right highlights the typical market distribution of Healthy Clinic, LLC. As the chart illustrates,

the majority of patients (70%) are usually referred to Healthy Clinic by doctors from partner clinics in the U.S.

Within this segment, one group of patients

consists of Americans looking for complementary

or alternative treatment options for their

condition, while the other group of patients is

considered incurable by their physician and

according to their doctor no further treatment

option is available in the US.

1 U.S. Census Bureau - 2013 www.quickfacts.census.gov

30%70%

Healthy Clinic, LLC Market Distribution

Direct Patients Referrals from Partnered Clinic

8

5 Sales Strategy

Healthy Clinic, LLC combines a set of local and latest advertising

technologies to effectively market its services across the local and domestic

markets. The company has secured the services of Goldman Marketing, a

leading local Public Relations agency, to provide promotional, advertising

and Public Relations expertise, and this relationship will enable Healthy

Clinic, LLC to deliver a highly effective, persistent marketing campaign

which will include grand opening events for its new Beverly Hills penthouse treatment facility, as well as

targeting promotion of Thymus wholesale products for U.S. medical practitioners. Educational seminars and

public lectures on the effectiveness of integrative and alternate treatments will be the mainstay of its local

marketing campaign these will also include television and radio appearances. In addition to this Healthy Clinic

will regularly publish articles in local lifestyle and national medical publications. Healthy Clinic will also rely on

word of mouth advertisement and referrals. Additional customers will be the direct result of referrals from

partner clinics and satisfied clients.

The ongoing sales strategy will focus on the following key areas:

1. Developing high-profile clients such as celebrities to increase awareness of the range of treatments

available, and hosting regular events;

2. Maintaining a strong marketing focus, ensuring that sufficient resources are available to exploit

potential opportunities;

3. Developing relationships with an increasing network of partner centers to increase referral

opportunities and to broaden network of patient treatments;

4. Engage in research and development to retain innovative focus;

5. Build on exceptional customer service, patient management and overall holistic treatment programs to

maintain and improve industry reputation.

5.1 Primary Marketing Campaign Strategy

The initial marketing efforts concentrate on the local market around Beverly Hills with particular focus on the

grand opening of the new Osteolitic Treatment Center in Beverly Hills. Ongoing marketing efforts will take

place in a continuous manner on a local and national scale, with the company working closely with Goldman

Marketing to deliver a highly professional, persistent and effective marketing campaign that will include the

following channels:

9

5.2 Sales Forecast

Healthy Clinic, LLC is expecting significant revenue growth over the next five years with sales forecast to rise

from $2.3 million to just over $9.2 million by the end of 2019. As the table below shows, this revenue growth

is primarily driven by Aminopeptide Therapy (and product) and Stem Cell Theraphy together.

Sales Forecast

Unit Sales 2015 2016 2017 2018 2019

Aminopeptide (therapy & product) 240 240 384 499 649

Integrative cancer care program 15 24 38 49 64

Stem cell therapy program 34 60 96 125 163

Autoimmune & lyme programs 60 60 96 125 163

Bodywork & IV therapies 927 1,044 1,670 2,171 2,822

Total Units 1,276 1,428 2,284 2,969 3,861

Aminopeptide (therapy & product) 900,000 927,120 1,527,936 2,044,902 2,739,429

Integrative cancer care program 300,000 494,400 806,284 1,070,895 1,440,704

Stem cell therapy program 629,000 1,143,300 1,884,192 2,527,000 3,393,986

Autoimmune & lyme programs 408,000 420,240 692,544 928,750 1,247,439

Bodywork & IV therapies 120,510 139,896 230,460 308,282 412,012

Total Sales $2,357,510 $3,124,956 $5,141,416 $6,879,829 $9,233,570

33% 65% 34% 34%

Direct Unit Costs 2015 2016 2017 2018 2019

Aminopeptide (therapy & product) 108,000 111,360 183,552 245,508 329,043

Integrative cancer care program 82,500 135,960 221,730 294,490 396,160

Stem cell therapy program 326,400 593,280 977,760 1,311,375 1,761,378

Autoimmune & lyme programs 75,000 77,280 127,392 170,875 229,504

Bodywork & IV therapies 41,715 48,024 78,490 104,208 138,278

Subtotal Direct Cost of Sales 633,615 965,904 1,588,924 2,126,456 2,854,363

10

6 Personnel Plan

This section examines the internal staffing structure of the company,

highlighting the relevant skills and experiences of the prospective E-2 visa

beneficiary. It will also provide an insight into the expected progression of

the company staffing requirements over the next five years, summarizing

the anticipated timetable and salary costs of any future appointments.

6.1 Company Structure

Healthy Clinic is organized as a Limited Liability Company (LLC), providing a flexible taxation structure for

the owners and the company. The company operates within a straightforward organizational hierarchy as

illustrated by the chart below, which shows the internal structure as of mid-2015 following the appointment of

Mr. John Smith as full-time U.S. CEO.

Managing Director

R&D Director

Medical Staff

Personal Assistant

CEO

COO

Office Manager

Acountant

PR Manager

Personal Assistant

11

6.3 Hiring Plan

Prior to the end of 2014 Healthy Clinic, LLC operated with five (5) U.S. employees, most of which were

appointed to focus on establishing the administrative and marketing framework of the company; this team

included an Office Manager, Public Relations Manager, a Physicians Assistant, and a Research & Development

Lab Director to help establish scientific protocols and research. The table below shows the expected growth in

staffing requirements following the appointment of Mr. John Smith as CEO in 2015. This expectation will lead

to a team of fifteen (15) full-time U.S. professionals by the end of 2019; the company will engage its medical

staff through self-managed medical corporations in order to comply with Californian State law.

Headcount Table

Employee Names/Titles 2015 2016 2017 2018 2019

Medical Team 5.0 5.0 6.0 9.0 9.0

Philip Battiade (Managing Director) 1.0 1.0 1.0 1.0 1.0

Naturopathic Doctor 1.0 1.0 2.0 3.0 3.0

Medical Doctor 1.0 1.0 1.0 2.0 2.0

Nurse 1.0 1.0 1.0 2.0 2.0

Tara Havens (R&D and Lab Director) 1.0 1.0 1.0 1.0 1.0

Other 0.0 0.0 0.0 0.0 0.0

Sales and Marketing 1.0 1.0 1.0 1.0 1.0

Katherine McDevitt (PR Manager) 1.0 1.0 1.0 1.0 1.0

Other 0.0 0.0 0.0 0.0 0.0

General and Administrative 3.0 3.0 3.0 3.0 3.0

Stephen Cox (Office Manager) 1.0 1.0 1.0 1.0 1.0

Assistants 2.0 2.0 2.0 2.0 2.0

Other 0.0 0.0 0.0 0.0 0.0

Executives 2.0 2.0 2.0 2.0 2.0

Daniel Beyer (C.E.O.) 1.0 1.0 1.0 1.0 1.0

Gina White (C.O.O.) 1.0 1.0 1.0 1.0 1.0

Total Staff 11.0 11.0 12.0 15.0 15.0

12

7 Financial Plan

In addition to the previously stated information regarding the company’s

mission, corporate objectives, operating activities, and sales and marketing

strategies, this section will further examine the long-term viability of the

business model and appraise the relative risk and return to investors, by

presenting a series of robust financial projection and modeling outcomes.

7.1 Projected Profit and Loss

The company is expected to increase profits over the next five years. The chart below left shows the

corresponding progression in the gross margin over the same five-year period, which will rise gradually from

53% to 58% with slight fluctuations as the company absorbs periodic costs associated with increasing its U.S.

team. This underlying stability in the gross margin reinforces the viability of the core business model, and will

contribute to significant profit growth over future years, and help drive further growth in the U.S. market.

As the chart above right illustrates that the company is anticipating a small net profit of almost $5,500 – after

taxes – during 2015, primarily as a result of the costs involved in rolling out its new treatment center in Beverly

Hills. The additional investment will help the company drive growth during subsequent years, with a strong

Marketing and Public Relation focus supporting the nascent expansion strategy that will see new satellite centers

becoming affiliated; as a result of this the company forecasts net profits rising from $273,000 to just over $2.7

million over the four year period to 2019. Over the same period the company’s net margin will improve from

9% to 30% as its operational and internal efficiencies stabilize. The full five-year profit and loss projection table

is shown on the following page. The gradual growth in gross margin is clearly evident, and once stabilized will

empower the leadership with the confidence to make informed strategic and operational decisions, helping the

company to achieve its long-term profit and growth objectives:

20%

40%

60%

$0

$2,000

$4,000

$6,000

2015 2016 2017 2018 2019

Tho

usa

nd

s

Synergy Health Gross Margin ForecastGross Margin Gross Margin %

0%

20%

40%

$0

$1,000

$2,000

$3,000

2015 2016 2017 2018 2019

Tho

usa

nd

s

Synergy Health Net Profits ForecastNet Earnings Net Margin

13

Profit & Loss Statement

2015 2016 2017 2018 2019

Sales $2,357,510 $3,124,956 $5,141,416 $6,879,829 $9,233,570

Direct Cost of Sales 633,615 965,904 1,588,924 2,126,456 2,854,363

Medical Team Payroll 498,800 513,764 677,703 995,256 1,025,113

Other 0 0 0 0 0

Total Cost of Sales 1,132,415 1,479,668 2,266,627 3,121,712 3,879,476

Gross Margin $1,225,095 $1,645,288 $2,874,789 $3,758,117 $5,354,094

Gross Margin % 52% 53% 56% 55% 58%

Sales and Marketing Expenses

Sales and Marketing Payroll 80,000 82,400 84,872 87,418 90,041

Advertising/Promotion 84,000 86,520 89,116 91,789 94,543

Auto 72,000 74,160 76,385 78,676 81,037

Travel 30,000 30,900 31,827 32,782 33,765

Total Sales and Marketing Expenses $266,000 $273,980 $282,199 $290,665 $299,385

General and Administrative Expenses

General and Administrative Payroll 180,000 185,400 190,962 196,691 202,592

Subcontractors 30,000 30,900 31,827 32,782 33,765

Rent 221,970 228,629 235,488 242,553 249,829

Office Expenses 14,400 14,832 15,277 15,735 16,207

Supplies (Medical & Business) 84,000 86,520 89,116 91,789 94,543

Utilities 24,000 24,720 25,462 26,225 27,012

Payroll Taxes, Insurance, Benefits 102,880 105,966 123,998 157,440 162,163

Other Operating Expenses 12,000 12,360 12,731 13,113 13,506

Total General and Administrative Expenses

$669,250 $689,328 $724,860 $776,328 $799,618

Other Expenses:

Executives Payroll 270,000 278,100 286,443 295,036 303,887 Audit Fees 0 0 0 0 0 Consultancy Fee (Accounting, Tax etc.) 0 0 0 0 0

Total Other Expenses $270,000 $278,100 $286,443 $295,036 $303,887

Total Operating Expenses $1,205,250 $1,241,408 $1,293,502 $1,362,030 $1,402,890

EBITDA $19,845 $403,881 $1,581,287 $2,396,088 $3,951,203

Interest Expense 0 0 0 0 0 Depreciation 12,067 13,164 13,164 13,164 13,164 Taxes Incurred 2,333 117,215 470,437 714,877 1,181,412

Net Earnings $5,445 $273,502 $1,097,686 $1,668,047 $2,756,627

Net Margin 0% 9% 21% 24% 30%

14

Appendix

The following information is presented in this plan to illustrate financial details, projections, general assumptions, and expected results. As in any

business plan, success is solely dependent on the business execution and the circumstances that surround its operations. The objective of these

projections is therefore to aid the entrepreneur on understanding the business model, along with the feasibility of such business development in

current market conditions and with the underlying assumptions considered only as part of this study.

Table 1: Sales Forecast

Sales Forecast

Unit Sales 1Q 2Q 3Q 4Q 2015 1Q 2Q 3Q 4Q 2016 2017 2018 2019

Aminopeptide (therapy & product) 60 60 60 60 240 60 60 60 60 240 384 499 649

Integrative cancer care program 3 3 4 5 15 6 6 6 6 24 38 49 64

Stem cell therapy program 4 7 10 13 34 15 15 15 15 60 96 125 163

Autoimmune & lyme programs 15 15 15 15 60 15 15 15 15 60 96 125 163

Bodywork & IV therapies 213 222 237 255 927 261 261 261 261 1,044 1,670 2,171 2,822

Total Units 295 307 326 348 1,276 357 357 357 357 1,428 2,284 2,969 3,861

Aminopeptide (therapy & product) 225,000 225,000 225,000 225,000 900,000 231,780 231,780 231,780 231,780 927,120 1,527,936 2,044,902 2,739,429

Integrative cancer care program 60,000 60,000 80,000 100,000 300,000 123,600 123,600 123,600 123,600 494,400 806,284 1,070,895 1,440,704

Stem cell therapy program 74,000 129,500 185,000 240,500 629,000 285,825 285,825 285,825 285,825 1,143,300 1,884,192 2,527,000 3,393,986

Autoimmune & lyme programs 102,000 102,000 102,000 102,000 408,000 105,060 105,060 105,060 105,060 420,240 692,544 928,750 1,247,439

Bodywork & IV therapies 27,690 28,860 30,810 33,150 120,510 34,974 34,974 34,974 34,974 139,896 230,460 308,282 412,012

Total Sales $488,690 $545,360 $622,810 $700,650 $2,357,510 $781,239 $781,239 $781,239 $781,239 $3,124,956 $5,141,416 $6,879,829 $9,233,570

33% 65% 34% 34%

Direct Unit Costs 2015 2016 2017 2018 2019

Aminopeptide (therapy & product) 27,000 27,000 27,000 27,000 108,000 27,840 27,840 27,840 27,840 111,360 183,552 245,508 329,043

Integrative cancer care program 16,500 16,500 22,000 27,500 82,500 33,990 33,990 33,990 33,990 135,960 221,730 294,490 396,160

Stem cell therapy program 38,400 67,200 96,000 124,800 326,400 148,320 148,320 148,320 148,320 593,280 977,760 1,311,375 1,761,378

Autoimmune & lyme programs 18,750 18,750 18,750 18,750 75,000 19,320 19,320 19,320 19,320 77,280 127,392 170,875 229,504

Bodywork & IV therapies 9,585 9,990 10,665 11,475 41,715 12,006 12,006 12,006 12,006 48,024 78,490 104,208 138,278

Subtotal Direct Cost of Sales 110,235 139,440 174,415 209,525 633,615 241,476 241,476 241,476 241,476 965,904 1,588,924 2,126,456 2,854,363

15

Table 3: Wages by Quarter

Expected Wages

Employee Names/Titles 1Q 2Q 3Q 4Q 2015 1Q 2Q 3Q 4Q 2016 2017 2018 2019

Medical Team $124,700 $124,700 $124,700 $124,700 $498,800 $128,441 $128,441 $128,441 $128,441 $513,764 $677,703 $995,256 $1,025,113

Philip Battiade (Managing Director) 37,500 37,500 37,500 37,500 150,000 38,625 38,625 38,625 38,625 154,500 159,135 163,909 168,826

Naturopathic Doctor 35,000 35,000 35,000 35,000 140,000 36,050 36,050 36,050 36,050 144,200 297,052 458,945 472,714

Medical Doctor 16,750 16,750 16,750 16,750 67,000 17,253 17,253 17,253 17,253 69,010 71,080 146,425 150,818

Nurse 16,250 16,250 16,250 16,250 65,000 16,738 16,738 16,738 16,738 66,950 68,959 142,055 146,316

Tara Havens (R&D and Lab Director) 19,200 19,200 19,200 19,200 76,800 19,776 19,776 19,776 19,776 79,104 81,477 83,921 86,439

Other 0 0 0 0 0 0 0 0 0 0 0 0 0

Sales and Marketing $20,000 $20,000 $20,000 $20,000 $80,000 $20,600 $20,600 $20,600 $20,600 $82,400 $84,872 $87,418 $90,041

Katherine McDevitt (PR Manager) 20,000 20,000 20,000 20,000 80,000 20,600 20,600 20,600 20,600 82,400 84,872 87,418 90,041

Other 0 0 0 0 0 0 0 0 0 0 0 0 0

General and Administrative $45,000 $45,000 $45,000 $45,000 $180,000 $46,350 $46,350 $46,350 $46,350 $185,400 $190,962 $196,691 $202,592

Stephen Cox (Office Manager) 25,000 25,000 25,000 25,000 100,000 25,750 25,750 25,750 25,750 103,000 106,090 109,273 112,551

Assistants 20,000 20,000 20,000 20,000 80,000 20,600 20,600 20,600 20,600 82,400 84,872 87,418 90,041

Other 0 0 0 0 0 0 0 0 0 0 0 0 0

Executives $67,500 $67,500 $67,500 $67,500 $270,000 $69,525 $69,525 $69,525 $69,525 $278,100 $286,443 $295,036 $303,887

Daniel Beyer (C.E.O.) 37,500 37,500 37,500 37,500 150,000 38,625 38,625 38,625 38,625 154,500 159,135 163,909 168,826

Gina White (C.O.O.) 30,000 30,000 30,000 30,000 120,000 30,900 30,900 30,900 30,900 123,600 127,308 131,127 135,061

Total Wages $257,200 $257,200 $257,200 $257,200 $1,028,800 $264,916 $264,916 $264,916 $264,916 $1,059,664 $1,239,980 $1,574,401 $1,621,633

Total Staff 11.0 11.0 11.0 11.0 11.0 11.0 11.0 11.0 11.0 11.0 12.0 15.0 15.0

16

Table 6: Quarterly Balance Sheet

Pro Forma Balance Sheet

1Q 2Q 3Q 4Q 2015 1Q 2Q 3Q 4Q 2016 2017 2018 2019AssetsCurrent Assets

Cash 1,562,591 1,533,053 1,535,796 1,588,935 1,588,935 1,686,104 1,787,074 1,888,044 1,871,799 1,871,799 2,768,423 4,162,974 6,548,034

Accounts Receivable 440,993 450,438 470,078 479,718 479,718 483,519 483,519 483,519 483,519 483,519 697,745 984,405 1,369,137

Inventory 7,049 7,049 7,049 7,049 7,049 7,049 7,049 7,049 7,049 7,049 7,049 7,049 7,049

Other Current Assets -1,053,100 -1,053,100 -1,053,100 -1,053,100 -1,053,100 -1,053,100 -1,053,100 -1,053,100 -1,053,100 -1,053,100 -1,053,100 -1,053,100 -1,053,100

Total Current Assets 957,532 937,440 959,822 1,022,601 1,022,601 1,123,571 1,224,542 1,325,512 1,309,267 1,309,267 2,420,117 4,101,327 6,871,119

Long-term Assets

Long-term Assets 219,386 219,386 219,386 219,386 219,386 219,386 219,386 219,386 219,386 219,386 219,386 219,386 219,386

Accumulated Depreciation 2,194 5,485 8,776 12,067 12,067 15,358 18,649 21,940 25,231 25,231 38,395 51,559 64,723

Total Long-term Assets 217,192 213,901 210,610 207,319 207,319 204,028 200,737 197,446 194,155 194,155 180,991 167,827 154,663

Total Assets $1,174,724 $1,151,340 $1,170,432 $1,229,920 $1,229,920 $1,327,599 $1,425,278 $1,522,957 $1,503,422 $1,503,422 $2,601,107 $4,269,154 $7,025,781

Liabilities and Equity

Current Liabilities

Accounts Payable 302,207 302,207 302,207 302,207 302,207 302,207 302,207 302,207 302,207 302,207 302,207 302,207 302,207

Current Borrowing -87,579 -87,579 -87,579 -87,579 -87,579 -87,579 -87,579 -87,579 -87,579 -87,579 -87,579 -87,579 -87,579

Other Liabilities 20,489 20,489 20,489 20,489 20,489 20,489 20,489 20,489 20,489 20,489 20,489 20,489 20,489

Total Current Liabilities 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118

Long Term Liabilities

Total Long Term Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0

Total Liabilities 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118 235,118

Equity

Paid-in Capital 1,561,838 1,561,838 1,561,838 1,561,838 1,561,838 1,561,838 1,561,838 1,561,838 1,561,838 1,561,838 1,561,838 1,561,838 1,561,838

Retained Earnings -622,232 -645,615 -626,524 -567,036 -567,036 -469,357 -371,678 -273,998 -293,534 -293,534 804,152 2,472,198 5,228,826

Total Equity 939,606 916,223 935,314 994,802 994,802 1,092,481 1,190,161 1,287,840 1,268,304 1,268,304 2,365,990 4,034,036 6,790,664

Total Liabilities and Equity $1,174,724 $1,151,340 $1,170,432 $1,229,920 $1,229,920 $1,327,599 $1,425,278 $1,522,957 $1,503,422 $1,503,422 $2,601,107 $4,269,154 $7,025,781

Net Worth $939,606 $916,223 $935,314 $994,802 $994,802 $1,092,481 $1,190,161 $1,287,840 $1,268,304 $1,268,304 $2,365,990 $4,034,036 $6,790,664